Form 4 for RAPP Rapport Therapeutics, Inc.
Accepted 2026-04-09 16:30:27 ET · period of report 2026-04-08 · accession 0001193125-26-149725 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-09 16:30 | 2026-04-08 | RAPP | Yeleswaram Krishnaswamy | Chief Development Off | S - Sale | $34.90 | -360 | 286.5K | -0.1% | -$12.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-08 | S | D | 360 | $34.90 | 286,516 | D | — | — | (F1) These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025. |